Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Gina Shishima (US)
ID:
1b8363dc-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
2 articles
FDA issues three final guidances on biosimilars
Health Law Pulse ·
May 4, 2015
cite
US Supreme Court rules isolated DNA is not patent-eligible
The Brand Protection Blog ·
June 19, 2013
cite
Practice Areas
Health Care and Life Sciences
Intellectual Property
Jurisdictions
North America
United States